UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating
Microsoft Analyst Ratings
BMO Capital Maintains Outperform on Microsoft, Raises Price Target to $500
Benchmark Maintains Buy on NVIDIA, Raises Price Target to $170
NVIDIA Analyst Ratings
JPMorgan raised Eli Lilly and Co's target price to $1,000.
BMO Capital Markets Adjusts Microsoft's Price Target to $500 From $465, Keeps Outperform Rating
Broadcom Analyst Ratings
Rosenblatt Maintains Buy on Broadcom, Raises Price Target to $2400
Rating upgrade | Rosenblatt: Raises Broadcom's target price to $2400, Believes ASIC Will Flourish
JP Morgan Maintains Overweight on Eli Lilly and Co, Raises Price Target to $1000
Wedbush Reiterates Outperform on Apple, Maintains $275 Price Target
Apple Analyst Ratings
B of A Securities Maintains Buy on Apple, Raises Price Target to $256
BofA Securities Raises Price Target on Apple to $256 From $230, Maintains Buy Rating
Rosenblatt Adjusts Price Target on Broadcom to $2,400 From $1,650
Analysts Offer Insights on Technology Companies: Rapid7 (RPD), Alarum Technologies (ALAR) and Broadcom (AVGO)
Deutsche Bank Adjusts Amazon.com's Price Target to $225 From $210, Keeps Buy Rating
Berenberg Adjusts Price Target on Eli Lilly & Co. to $1,000 From $850, Maintains Buy Rating
TD Cowen raises Meta's target price to 600 US dollars